Recent Updates
Recently added Catalysts
RMD Positive Sentiment Score: 70/100

ResMed to Report Third Quarter Fiscal 2023 Earnings on April 27, 2023

Key Takeaway: SAN DIEGO, April 06, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the third quarter of fiscal year 2023 on Thursday, April 27, 2023, after the New York Stock Exchange closes. Following the release,

Market Sentiment Analysis

POSITIVE FACTORS

  • ResMed is set to announce its third quarter earnings, indicating ongoing business operations.
  • The management will provide a platform for open communication through a webcast.
  • ResMed's innovative technology solutions are highlighted, suggesting a strong product offering.

Full Press Release Details

SAN DIEGO, April 06, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the third quarter of fiscal year 2023 on Thursday, April 27, 2023, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast.
Earnings webcast details:
Location: http://investor.resmed.com
Date: Thursday, April 27, 2023
Time: 1:30 p.m. PDT / 4:30 p.m. EDT
International: London, Thursday, April 27, 2023, 9:30 p.m. BST
Sydney, Friday, April 28, 2023, 6:30 a.m. AEST
Please note, ResMed does not use outside phone lines to access the earnings call, the call is accessible via the above webcast link only.
A replay of the earnings webcast will be accessible on ResMed’s website and available approximately two hours after the webcast. In addition, a phone replay will be available approximately three hours after the webcast and will be accessible from April 27, 2023, until May 11, 2023, at:
U.S.: +1 877.660.6853
International: +1 201.612.7415
Conference ID: 13737758
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries. To learn more, visit ResMed.com and follow @ResMed.
For investors For media
Amy Wakeham Jayme Rubenstein
+1 858.836.5000 +1 858.836.6798
investorrelations@resmed.com news@resmed.com

Frequently Asked Questions

When will ResMed release its Q3 2023 financial results?

ResMed will release its Q3 2023 financial results on April 27, 2023.

What time is the ResMed earnings webcast scheduled?

The earnings webcast is set for 1:30 p.m. PDT on April 27, 2023.

How can I access the ResMed earnings call?

The earnings call can be accessed exclusively through the webcast link provided.

Will a replay of the earnings webcast be available?

Yes, a replay will be available on ResMed’s website two hours after the webcast.

What is the conference ID for the phone replay?

The conference ID for the phone replay is 13737758.

Last updated: Apr 6, 2023